文献速递血液净化与透析

血液透析患者SARS-CoV-2 IgG抗体感染后六个月的动力学变化

Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
PubMed 文献 · J Am Soc Nephrol · 2021-02-26

该研究回顾性分析了法国巴黎地区83例感染COVID-19后康复的血液透析患者,随访至诊断后6个月,评估SARS-CoV-2 IgG抗体(针对核衣壳抗原和刺突抗原)的初始及长期体液免疫应答。结果显示89%患者初始抗核衣壳IgG阳性,免疫抑制状态是唯一与无抗体应答相关的因素;6个月时25%初始阳性患者抗核衣壳抗体转阴,女性、年龄>70岁和非重症临床表现与抗体滴度下降更快独立相关。

要点

  • 血液透析患者感染SARS-CoV-2后6个月内抗体可转阴,需关注免疫持久性。
  • 免疫抑制状态与缺乏抗核衣壳IgG抗体应答显著相关。
  • 女性、年龄>70岁及非重症临床表现与抗体滴度更快下降独立相关。

核心结论

  • 血液透析患者感染SARS-CoV-2后6个月内部分患者抗核衣壳IgG转阴,免疫抑制状态与无抗体应答相关,女性、高龄和非重症与抗体衰减更快相关。

研究设计与样本

  • 回顾性研究,纳入法国巴黎地区83例感染COVID-19后康复的血液透析患者,中位年龄65岁,随访至诊断后6个月。

主要发现

  • 74例(89%)在中位诊断后67天抗核衣壳IgG阳性。
  • 60例初始抗核衣壳IgG阳性且有6个月随访数据的患者中,15例(25%)在6个月时抗核衣壳IgG转阴;其中14例检测了抗刺突抗体,3例(21%)同时阴性。
  • 97%的抗核衣壳抗体阳性标本也抗刺突抗体阳性。
  • 多变量分析显示免疫抑制状态是唯一与缺乏抗核衣壳IgG应答显著相关的因素。
  • 女性、年龄>70岁和非重症临床表现与抗核衣壳IgG滴度更快衰减独立相关;调整性别和年龄后,非重症临床表现是唯一与抗刺突IgG更快衰减相关的因素。

临床怎么用

  • 对血液透析患者,尤其是免疫抑制者,感染后6个月内应关注抗体转阴风险,可能需要加强监测或疫苗接种策略。

局限性

  • 回顾性研究,样本量有限,随访时间仅6个月,未报告抗体滴度的具体数值和统计学细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the hemodialysis population, including its dynamics over time, remains poorly understood. METHODS: To analyze initial and long-term humoral responses against SARS-CoV-2 in a hemodialysis population, we retrospectively evaluated findings from SARS-CoV-2 IgG serologic assays targeting the nucleocapsid antigen or spike antigen up to 6 months of follow-up in patients on hemodialysis in the Paris, France, region who had recovered from coronavirus disease 2019 (COVID-19). RESULTS: Our analysis included 83 patients (median age 65 years); 59 (71%) were male and 28 (34%) had presented with severe COVID-19. We observed positive initial SARS-CoV-2 IgG antinucleocapsid serology in 74 patients (89%) at a median of 67 days postdiagnosis. By multivariable analysis, immunocompromised status was the only factor significantly associated with lack of an IgG antinucleocapsid antibody response. Follow-up data were available at 6 months postdiagnosis for 60 of 74 patients (81%) with positive initial antinucleocapsid serology, and 15 (25%) of them had negative antinucleocapsid serology at month 6. In total, 14 of 15 sera were tested for antispike antibodies, 3 of 14 (21%) of which were also negative. Overall, 97% of antinucleocapsid-antibody-positive specimens were also antispike-antibody positive. Female sex, age >70 years, and nonsevere clinical presentation were independently associated with faster IgG antinucleocapsid titer decay in multivariable analysis. After adjustment for sex and age >70 years, nonsevere clinical presentation was the only factor associated with faster decay of IgG antispike antibodies. CONCLUSIONS: This study characterizes evolution of the SARS-CoV-2 antibody response in patients on hemodialysis and identifies factors that are associated with lack of seroconversion and with IgG titer decay.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sakhi H, Dahmane D, Attias P, et al. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection. J Am Soc Nephrol. 2021. PMID: 33637518. doi:10.1681/ASN.2020111618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。